-
Everolimus is the newest oral kinase inhibitor approved for the treatment of advanced renal cell carcinoma.
-
The ACCORD trial has been newsworthy in the last several months primarily due to the early results of increased cardiovascular events associated with very tight glucose control.
-
The simultaneously obtained lead II and lead V1 rhythm strip seen above was interpreted as showing atrial fibrillation with a rapid ventricular response. Do you agree?
-
-
Some natural products are not so "natural" after all.
-
Increasing evidence suggests that proton pump inhibitors (PPIs) may attenuate the effect of clopidogrel on platelet aggregation.
-
What is the best dose of aspirin for patients taking dual therapy with clopidogrel to prevent cardiovascular events?
-
Modafinil (Provigil®) is a wake-promoting medication used to treat narcolepsy and other sleep disorders.
-
The FDA is requiring the manufacturers of metoclopramide (Reglan®) include a boxed warning on their labeling regarding the risk of long-term or high-dose use and tardive dyskinesia.
-
